EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review

Kaia C Miller, Bridget Geyer, Anastasia-Stefania Alexopoulos, Cynthia A Moylan, Neha Pagidipati

Digestive Diseases and Sciences · 2025-01 · 70 (1) · 154-167

DOI: 10.1007/s10620-024-08722-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 19.11.2024. Verfasst von Kaia C Miller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Duke University, Durham, NC, USA. kaia.miller@duke.edu. Hauptthemen laut MEDLINE: Health Status Disparities, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a leading cause of morbidity and mortality, and health disparities have been shown to influence disease burden. AIM: In this review, we aim to characterize disparities in prevalence, diagnosis, treatment, and outcomes of MASLD, and to make recommendations for next steps to minimize these disparities. METHODS: Literature search on PubMed and Scopus databases was conducted to identify relevant articles published before September 2, 2024. RESULTS: Relative to women and White populations, MASLD is more common in men and Hispanic populations and less common in Black populations. It is also more prevalent among those with lower SES. Noninvasive clinical scores may perform differently across groups, and screening practices vary both for initial disease and for progression to metabolic dysfunctionassociated steatohepatitis (MASH), formerly called non-alcoholic steatohepatitis (NASH). Women and Black and Hispanic patients suffer worse outcomes including rates of progression to MASH and mortality. CONCLUSIONS: Health disparities related to race, ethnicity, gender, and socioeconomic factors impact multiple stages of care for patients with MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health Status DisparitiesNon-alcoholic Fatty Liver DiseaseFemaleHumansMaleHealthcare DisparitiesHispanic or LatinoPrevalenceSex FactorsTreatment OutcomeRacial Groups

Stichwörter der Autor:innen

DisparitiesFatty liver diseaseMASHMASLDMetabolic syndromeNAFLDNASH

Autor:innen und Institutionen

  • Duke University, Durham, NC, USA. kaia.miller@duke.edu.
  • Vanderbilt University, Nashville, TN, USA.
  • Duke University, Durham, NC, USA.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Miller, K. C., Geyer, B., Alexopoulos, A. S., Moylan, C. A., & Pagidipati, N. (2025). Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review. Digestive Diseases and Sciences, 70(1), 154-167. https://doi.org/10.1007/s10620-024-08722-0

Vancouver

Miller KC, Geyer B, Alexopoulos AS, Moylan CA, Pagidipati N. Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review. Digestive Diseases and Sciences. 2025;70(1):154-167. doi:10.1007/s10620-024-08722-0

BibTeX
@article{Miller2025,
  author = {Miller, Kaia C and Geyer, Bridget and Alexopoulos, Anastasia-Stefania and Moylan, Cynthia A and Pagidipati, Neha},
  title = {Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  volume = {70},
  number = {1},
  pages = {154--167},
  doi = {10.1007/s10620-024-08722-0}
}
Kostenlos starten →